About Desano Pharmaceuticals Private Limited
Data last updated: 20 December 2025
Desano Pharmaceuticals Private Limited is a foreign private limited company based in Bengaluru, Karnataka, India, a subsidiary of Desano Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 19 November 2012, the company has been in operation for over 14 years.
Registered with ROC Bangalore under CIN U24233KA2012FTC130244.
Capital: an authorised share capital of ₹55 Cr and a paid-up capital of ₹49.69 Cr. It is led by directors Li Jingpeng and Sasikumar Kannaiyan.
Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: No. 77D Kiadb Industrial Area Jigani, Bengaluru, Karnataka, India – 560105.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.05 Cr, reflecting significant growth compared to the previous year.
The company has a workforce of approximately 163 employees as per the latest available data. It operates as a subsidiary of Desano Limited.
The company is associated with 1 brand - Shanghai Desano Chemical Pharmaceuticals. As per MCA filings, the company has open charges of ₹50 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website desano.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressNo. 77D Kiadb Industrial Area Jigani, Bengaluru, Karnataka, India – 560105
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals Private Limited has one previous CIN (Corporate Identification Number): U24233MH2012FTC238017. The current CIN is U24233KA2012FTC130244, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233KA2012FTC130244 | Current |
| U24233MH2012FTC238017 | Previous |
Associated Brands with Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals Private Limited operates one associated brand: Shanghai Desano Chemical Pharmaceuticals. These brands represent Desano Pharmaceuticals Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Generic APIs and FPPs are researched and manufactured. | desano.com |
Competitors & Alternatives of Desano Pharmaceuticals Private Limited
Brands and companies operating in the same space as Desano Pharmaceuticals Private Limited include Concord Biotech, Almac Group, Indoco Remedies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Aurobindo Pharma
|
Generic biocatalytic solutions are provided for pharmaceutical applications. | Hyderabad, India, India | 1986 |
Seqens
|
Contract manufacturing services for small molecules and peptides are provided. | Ecully, France, France | 2003 |
Asymchem
|
APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States, United States | 1995 |
Aptuit
|
Contract research and development services for small molecules are offered. | Greenwich, United States, United States | 2004 |
Continuus Pharma
|
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States, United States | 2012 |
Auditor Details of Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals Private Limited is audited by RAMAMIRTHAM NATARAJAN & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAMAMIRTHAM NATARAJAN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Desano Pharmaceuticals Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals Private Limited is currently managed by 2 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Li Jingpeng | Director | 19 Nov 2012 | 13 Years 8 Months | Current |
| Sasikumar Kannaiyan | Director | 15 Nov 2019 | 6 Years 8 Months | Current |
Financials of Desano Pharmaceuticals Private Limited FY 2025 filings available
Desano Pharmaceuticals Private Limited reported revenue of ₹1.05 Cr (up 282.00% YoY) for FY 2025.
Ten-year financial statements for Desano Pharmaceuticals Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Desano Pharmaceuticals Private Limited
Shareholding and ownership data for Desano Pharmaceuticals Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Desano Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Apr 2024 | Others | ₹50 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals Private Limited has a workforce of 163 employees as of Apr 05, 2024.
Employee and EPFO history for Desano Pharmaceuticals Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Desano Pharmaceuticals Private Limited
GST registrations and filing compliance for Desano Pharmaceuticals Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Desano Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts for Desano Pharmaceuticals Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Desano Pharmaceuticals Private Limited
MSME payment history for Desano Pharmaceuticals Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Desano Pharmaceuticals Private Limited
Corporate group structure for Desano Pharmaceuticals Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Desano Pharmaceuticals Private Limited
MCA filings and documents for Desano Pharmaceuticals Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Desano Pharmaceuticals Private Limited
Frequently Asked Questions about Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals Private Limited is an active foreign private limited company in the pharma sector based in Bengaluru, Karnataka, India. It was incorporated on 19 November 2012 (14+ years old) and is registered under CIN U24233KA2012FTC130244. The company has 163 employees.
Desano Pharmaceuticals Private Limited reported revenue of ₹1.05 Cr for FY 2025 (up 282.00% YoY).
The current directors of Desano Pharmaceuticals Private Limited are:
- Li Jingpeng - Director
- Sasikumar Kannaiyan - Director
The primary industry of Desano Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Desano Pharmaceuticals Private Limited can be reached at the registered office: No. 77D Kiadb Industrial Area Jigani, Bengaluru, Karnataka, India – 560105, or through the website desano.com.
The authorised capital is ₹55 Cr, and the paid-up capital is ₹49.69 Cr.